Timing of Local Therapy Affects Survival in Ewing Sarcoma.

[1]  S. McGovern,et al.  Proton therapy for pediatric malignancies: Fact, figures and costs. A joint consensus statement from the pediatric subcommittee of PTCOG, PROS and EPTN. , 2018, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[2]  Kimberly J. Johnson,et al.  The effect of health insurance on childhood cancer survival in the United States , 2017, Cancer.

[3]  Amy P. Hardin,et al.  Age Limit of Pediatrics , 2017, Pediatrics.

[4]  T. Strom,et al.  Having Medicaid insurance negatively impacts outcomes in patients with head and neck malignancies , 2016, Cancer.

[5]  B. Yeap,et al.  Proton radiotherapy for pediatric Ewing's sarcoma: initial clinical outcomes. , 2012, International journal of radiation oncology, biology, physics.

[6]  S. Hopyan,et al.  Clinical outcome of children and adults with localized Ewing sarcoma , 2010, Cancer.

[7]  J. Zell,et al.  Analysis of prognostic factors in Ewing sarcoma using a population‐based cancer registry , 2010, Cancer.

[8]  B. Wen,et al.  Dose response and local control using radiotherapy in non‐metastatic Ewing sarcoma , 2007, Pediatric blood & cancer.

[9]  J. Gardiner,et al.  Cancer, Medicaid enrollment, and survival disparities , 2005, Cancer.

[10]  A. Schuck,et al.  Role of radiotherapy in Ewing tumors , 2004, Pediatric blood & cancer.

[11]  C. R. Pinkerton,et al.  Outcome after relapse in an unselected cohort of children and adolescents with Ewing sarcoma. , 2003, Medical and pediatric oncology.

[12]  W. Winkelmann,et al.  Local therapy in localized Ewing tumors: results of 1058 patients treated in the CESS 81, CESS 86, and EICESS 92 trials. , 2003, International journal of radiation oncology, biology, physics.

[13]  B. Bui,et al.  Prognostic factors in localized Ewing's tumours and peripheral neuroectodermal tumours: the third study of the French Society of Paediatric Oncology (EW88 study) , 2001, British Journal of Cancer.

[14]  W. Winkelmann,et al.  Localized Ewing tumor of bone: final results of the cooperative Ewing's Sarcoma Study CESS 86. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  C. Blomqvist,et al.  Five-year results in Ewing's sarcoma. The Scandinavian Sarcoma Group experience with the SSG IX protocol. , 2000, European journal of cancer.

[16]  H. Jürgens,et al.  Deskriptive Epidemiologie der Ewing-Tumoren - Analysen der deutschen Patienten von (EI) CESS 1980-1997* , 1999 .

[17]  B. Dockhorn-Dworniczak,et al.  EICESS 92 (European Intergroup Cooperative Ewing's Sarcoma Study) - Erste Ergebnisse , 1999 .

[18]  W. Reinus,et al.  A multidisciplinary study investigating radiotherapy in Ewing's sarcoma: end results of POG #8346. Pediatric Oncology Group. , 1998, International journal of radiation oncology, biology, physics.

[19]  W. Winkelmann,et al.  Primary metastatic (stage IV) Ewing tumor: survival analysis of 171 patients from the EICESS studies. European Intergroup Cooperative Ewing Sarcoma Studies. , 1998, Annals of oncology : official journal of the European Society for Medical Oncology.

[20]  J. W. van der Eijken,et al.  Ewing's sarcoma of the pelvis: changes over 25 years in treatment and results. , 1997, European journal of cancer.

[21]  L. Robison,et al.  Incidence of cancer in children in the United States. Sex‐, race‐, and 1‐year age‐specific rates by histologic type , 1995, Cancer.

[22]  U. Göbel,et al.  Die kooperative Ewing-Sarkom-Studie CESS 81 der GPO - Analyse nach 4 Jahren* +( * , 1985 .